70 results on '"Amuchastegui, S."'
Search Results
2. Transplantation tolerance by 1,25-dihydroxyvitamin D3-induced costimulation blockade
3. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+FoxP3+ regulatory T-cells by 1,25-dihydroxyvitamin D3
4. HUMAN BENIGN PROSTATIC HYPERPLASIA CELLS AS INDUCERS AND TARGETS OF CHRONIC AUTOIMMUNE INFLAMMATION
5. Manipulating dendritic cells to induce regulatory T cells
6. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.
7. The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes.
8. Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.
9. Renal cyclophilin-like protein gene expression parallels changes in sodium excretion in experimental nephrosis and is positively modulated by atrial natriuretic peptide.
10. 93 HUMAN BENIGN PROSTATIC HYPERPLASIA CELLS AS INDUCERS AND TARGETS OF CHRONIC AUTOIMMUNE INFLAMMATION
11. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3
12. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration
13. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol
14. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
15. Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation.
16. Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells.
17. Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse.
18. Vitamin D receptor agonists as anti-inflammatory agents.
19. Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol).
20. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
21. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells.
22. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol.
23. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.
24. Prevention of chronic allograft rejection by Vitamin D receptor agonists.
25. Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist.
26. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.
27. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands.
28. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
29. Nonviral and viral gene transfer to the kidney in the context of transplantation.
30. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
31. CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat.
32. [Medical treatment of the complete auriculoventricular block. Special reference to 3,5 isopropyla minoethane].
33. [Peculiarities of respiration and oxygen consumption in pulmonary tuberculosis].
34. [Social medicine in relation to the problem of brucellosis].
35. [Tetralogy of Fallot & right aortic arch].
36. Heart disease and brucellosis.
37. [The state and graduate medical training].
38. [Disseminated form of histoplasmosis; clinical case report with favorable outcome].
39. [Anatomo-functional correlation of the kidney in various nephropathies].
40. [Clinical and hemodynamic study of a new antihypertensive agent].
41. [Tricuspid atresia. Report of a case].
42. [Professional dignity].
43. [Congenital heart diseases. Clinical, electro-cardiographical and hemodynamic evaluation of the results of its surgical treatment with extracorporeal circulation].
44. [Disseminated form of histoplasmosis].
45. Brucellosis control plan.
46. [Students].
47. [Cardiorespiratory function in thoracoplasty or extrapleural pneumothorax in pulmonary tuberculosis].
48. [CORONARY ARTERIOVENOUS FISTULA. REPORT OF A CASE].
49. [Action of a new beta adrenergic blocking agent on various cardiac arrhytmias and subaortic idiopathic stenosis. Preliminary report].
50. [Symptomatic management of Chagas' heart disease using a beta-adrenergic blocking agent].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.